Insys Therapeutics Inc. (NASDAQ:INSY) on Tuesday reported fourth-quarter net income of $9.3 million. On a per-share basis, the Chandler, Arizona-based company said it had net income of 25 cents. Earnings, adjusted for stock option expense, were 53 cents per share. The specialty pharmaceutical company posted revenue of $66.5 million in the period, surpassing Street forecasts. Analysts expected $64.6 million, according to Zacks. On Tuesday shares of INSYS Therapeutics, Inc. (NASDAQ:INSY) closed at $55.98. Company’s EPS growth for next 5 years is recorded as 28.00%.
JD.com, Inc. (NASDAQ:JD) appears to have been a victim of the old market maxim of ‘buy the rumor, sell the fact’ after delivering stellar fourth quarter earnings. Company announcing a whopping 119% increase in gross merchandise volume (GMV), or dollar value of sales, compared to the same time last year. The company unveiled a profit of $13.5 million, which exceeded analyst expectations for a small loss but was calculated using non- generally accepted accounting principles (GAAP). JD.com, Inc. (NASDAQ:JD) in last trading activity decreased -2.20% to close at $27.53. Company weekly performance is 0.15% while its quarterly performance stands at 17.05%. JD.com, Inc. (NASDAQ:JD) is -16.83% away from its 52 week high.
Bank of America upgraded shares of Genesee & Wyoming (NYSE:GWR) from a neutral rating to a buy rating in a research report sent to investors on Thursday. On last trading day Genesee & Wyoming Inc. (NYSE:GWR) decreased -2.06% to close at $102.98. Its volatility for the week is 2.20% while volatility for the month is 2.16%. GWR’s sales growth for past 5 years was 24.60% and its EPS growth for past 5 years was 24.40%. Genesee & Wyoming Inc. (NYSE:GWR) monthly performance is 24.90%.
Johnson & Johnson (NYSE:JNJ) announced the grand opening of a biotech incubator in South San Francisco on Tuesday and unveiled the first 10 businesses that will reside there. The 30,000-square foot facility can house up to 50 startups at a time, and its members will focus on developing healthcare solutions in the highly competitive industries of pharmaceuticals, medical devices and digital health. On Tuesday shares of Johnson & Johnson (NYSE:JNJ) closed at $102.34. Company’s sales growth for last 5 years was 3.70% and EPS growth for next 5 years is recorded as 5.96%.
Choice Hotels International, Inc (NYSE:CHH) is honoring the highest rated properties within its portfolio of more than 6,300 franchised hotels around the world by announcing the winners of its prestigious 2015 Platinum Hospitality Awards. On last trading day Choice Hotels International Inc. (NYSE:CHH) decreased -1.82% to close at $62.62. Its volatility for the week is 1.51% while volatility for the month is 1.97%. CHH’s sales growth for past 5 years was 6.10% and its EPS growth for past 5 years was 4.90%. Choice Hotels International Inc. (NYSE:CHH) monthly performance is 9.00%.